US life science firms pulling less cash from ATMs
This article was originally published in Scrip
Executive Summary
More US life science companies filed documents to facilitate at-the-market (ATM) offerings than ever before during the second quarter of 2012, but the industry raised less money from ATMs compared to the second quarter of 2011, according to Brinson Patrick Securities.